{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:57:40Z","timestamp":1793833060750,"version":"4.6.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Key R&D Program for Young Scientists","award":["2022YFC2505700"],"award-info":[{"award-number":["2022YFC2505700"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473407"],"award-info":[{"award-number":["82473407"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Education Cultivation Fund of the National Cancer and Regional Medical Centre of Shanxi Provincial Cancer Hospital","award":["TD2023001, BD2023002, and SD2023034"],"award-info":[{"award-number":["TD2023001, BD2023002, and SD2023034"]}],"id":[{"id":"https:\/\/ror.org\/01790dx02","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Beijing Physician Scientist Training Project","award":["BJPSTP-2024-02"],"award-info":[{"award-number":["BJPSTP-2024-02"]}]},{"name":"Natural Science Foundation of Science and Technology Department of Shanxi Province","award":["202303021211232"],"award-info":[{"award-number":["202303021211232"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04187-w","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:37:40Z","timestamp":1759761460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Tumor-draining lymph nodes respond to immune checkpoint inhibition and orchestrate tumor immune remodeling"],"prefix":"10.1007","volume":"74","author":[{"given":"Jinzhu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhexue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likun","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xishan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"issue":"3","key":"4187_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"4187_CR2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1158\/2159-8290.CD-24-0217","volume":"14","author":"R Yaeger","year":"2024","unstructured":"Yaeger R, Uboha NV, Pelster MS, Bekaii-Saab TS, Barve M, Saltzman J et al (2024) Efficacy and safety of adagrasib plus cetuximab in patients with KRASG12C-Mutated metastatic colorectal cancer. Cancer Discov 14(6):982\u2013993","journal-title":"Cancer Discov"},{"key":"4187_CR3","doi-asserted-by":"crossref","first-page":"103207","DOI":"10.1016\/j.redox.2024.103207","volume":"73","author":"S Dong","year":"2024","unstructured":"Dong S, Zhang M, Cheng Z, Zhang X, Liang W, Li S et al (2024) Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer. Redox Biol 73:103207","journal-title":"Redox Biol"},{"key":"4187_CR4","doi-asserted-by":"crossref","first-page":"117363","DOI":"10.1016\/j.biopha.2024.117363","volume":"179","author":"R Zhang","year":"2024","unstructured":"Zhang R, Su C, Jia Y, Xing M, Jin S, Zong H (2024) Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer. Biomed Pharmacother 179:117363","journal-title":"Biomed Pharmacother"},{"issue":"18","key":"4187_CR5","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1158\/0008-5472.CAN-21-1500","volume":"81","author":"A Velalopoulou","year":"2021","unstructured":"Velalopoulou A, Karagounis IV, Cramer GM, Kim MM, Skoufos G, Goia D et al (2021) FLASH proton radiotherapy spares normal epithelial and mesenchymal tissues while preserving sarcoma response. Cancer Res 81(18):4808\u20134821","journal-title":"Cancer Res"},{"issue":"6382","key":"4187_CR6","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science 359(6382):1350\u20131355","journal-title":"Science"},{"issue":"7","key":"4187_CR7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S1470-2045(24)00203-1","volume":"25","author":"JH Yu","year":"2024","unstructured":"Yu JH, Xiao BY, Li DD, Jiang W, Ding Y, Wu XJ et al (2024) Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study. Lancet Oncol 25(7):843\u2013852","journal-title":"Lancet Oncol"},{"issue":"6","key":"4187_CR8","doi-asserted-by":"crossref","first-page":"e004703","DOI":"10.1136\/jitc-2022-004703","volume":"10","author":"Z Wang","year":"2022","unstructured":"Wang Z, Zhang Q, Qi C, Bai Y, Zhao F, Chen H et al (2022) Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR\/MSI-H gastrointestinal cancer. J Immunother Cancer 10(6):e004703","journal-title":"J Immunother Cancer"},{"issue":"2","key":"4187_CR9","doi-asserted-by":"crossref","first-page":"e004001","DOI":"10.1136\/jitc-2021-004001","volume":"10","author":"G Fuc\u00e0","year":"2022","unstructured":"Fuc\u00e0 G, Cohen R, Lonardi S, Shitara K, Elez ME, Fakih M et al (2022) Ascites and resistance to immune checkpoint inhibition in dMMR\/MSI-H metastatic colorectal and gastric cancers. J Immunother Cancer 10(2):e004001","journal-title":"J Immunother Cancer"},{"issue":"11","key":"4187_CR10","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.ccell.2023.09.011","volume":"41","author":"Z Liu","year":"2023","unstructured":"Liu Z, Zhang Y, Ma N, Yang Y, Ma Y, Wang F et al (2023) Progenitor-like exhausted SPRY1(+)CD8(+)\u00a0T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma. Cancer Cell 41(11):1852-1870.e1859","journal-title":"Cancer Cell"},{"issue":"3","key":"4187_CR11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller BC, Sen DR, Al Abosy R, Bi K, Virkud YV, LaFleur MW et al (2019) Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol 20(3):326\u2013336","journal-title":"Nat Immunol"},{"issue":"22","key":"4187_CR12","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","volume":"185","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wu X, Wang Z, Chen X, Wang L, Lu Y et al (2022) The primordial differentiation of tumor-specific memory CD8(+) T\u00a0cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell 185(22):4049-4066.e4025","journal-title":"Cell"},{"issue":"12","key":"4187_CR13","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1038\/s43018-024-00870-6","volume":"5","author":"K Nutsch","year":"2024","unstructured":"Nutsch K, Banta KL, Wu TD, Tran CW, Mittman S, Duong E et al (2024) TIGIT and PD-L1 co-blockade promotes clonal expansion of multipotent, non-exhausted antitumor T cells by facilitating co-stimulation. Nat Cancer 5(12):1834\u20131851","journal-title":"Nat Cancer"},{"issue":"6","key":"4187_CR14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.immuni.2019.10.009","volume":"51","author":"R Zander","year":"2019","unstructured":"Zander R, Schauder D, Xin G, Nguyen C, Wu X, Zajac A, Cui W (2019) CD4(+) T cell help is required for the formation of a cytolytic CD8(+) T cell subset that protects against chronic infection and cancer. Immunity 51(6):1028-1042.e1024","journal-title":"Immunity"},{"issue":"8","key":"4187_CR15","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1158\/0008-5472.CAN-13-2928","volume":"74","author":"Y Wang","year":"2014","unstructured":"Wang Y, Sparwasser T, Figlin R, Kim HL (2014) Foxp3+ T cells inhibit antitumor immune memory modulated by mTOR inhibition. Cancer Res 74(8):2217\u20132228","journal-title":"Cancer Res"},{"key":"4187_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002157","author":"J Niogret","year":"2021","unstructured":"Niogret J, Berger H, Rebe C, Mary R, Ballot E, Truntzer C et al (2021) Follicular helper-T cells restore CD8(+)-dependent antitumor immunity and anti-PD-L1\/PD-1 efficacy. J Immunother Cancer https:\/\/doi.org\/10.1136\/jitc-2020-002157","journal-title":"J Immunother Cancer"},{"issue":"8","key":"4187_CR17","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41590-021-00958-6","volume":"22","author":"S Eschweiler","year":"2021","unstructured":"Eschweiler S, Clarke J, Ram\u00edrez-Su\u00e1stegui C, Panwar B, Madrigal A, Chee SJ et al (2021) Intratumoral follicular regulatory T cells curtail anti-PD-1 treatment efficacy. Nat Immunol 22(8):1052\u20131063","journal-title":"Nat Immunol"},{"issue":"4","key":"4187_CR18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.it.2022.02.010","volume":"43","author":"L Schmidleithner","year":"2022","unstructured":"Schmidleithner L, Feuerer M (2022) Tfh cells induce intratumoral tertiary lymphoid structures. Trends Immunol 43(4):274\u2013276","journal-title":"Trends Immunol"},{"issue":"6280","key":"4187_CR19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1126\/science.aaf1490","volume":"351","author":"N McGranahan","year":"2016","unstructured":"McGranahan N, Furness AJ, Rosenthal R, Ramskov S, Lyngaa R, Saini SK et al (2016) Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science 351(6280):1463\u20131469","journal-title":"Science"},{"issue":"8","key":"4187_CR20","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1158\/0008-5472.CAN-23-3918","volume":"85","author":"KM Mahuron","year":"2025","unstructured":"Mahuron KM, Shahid O, Sao P, Wu C, Haugh AM, Huppert LA et al (2025) Single-cell analyses reveal a functionally heterogeneous exhausted CD8+ T-cell subpopulation that is correlated with response to checkpoint therapy in Melanoma. Cancer Res 85(8):1424\u20131440","journal-title":"Cancer Res"},{"issue":"7","key":"4187_CR21","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ccell.2024.06.009","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen Y, Wang D, Li Y, Qi L, Si W, Bo Y et al (2024) Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer. Cancer Cell 42(7):1268-1285.e1267","journal-title":"Cancer Cell"},{"issue":"1","key":"4187_CR22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1186\/s12864-018-4772-0","volume":"19","author":"K Street","year":"2018","unstructured":"Street K, Risso D, Fletcher RB, Das D, Ngai J, Yosef N et al (2018) Slingshot: cell lineage and pseudotime inference for single-cell transcriptomics. BMC Genomics 19(1):477","journal-title":"BMC Genomics"},{"issue":"99","key":"4187_CR23","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adi3487","volume":"9","author":"DM Morgan","year":"2024","unstructured":"Morgan DM, Horton BL, Bhandarkar V, Van R, Dinter T, Zagorulya M et al (2024) Expansion of tumor-reactive CD8(+) T cell clonotypes occurs in the spleen in response to immune checkpoint blockade. Sci Immunol 9(99):eadi3487","journal-title":"Sci Immunol"},{"issue":"6","key":"4187_CR24","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.cell.2023.02.021","volume":"186","author":"MK Rahim","year":"2023","unstructured":"Rahim MK, Okholm TLH, Jones KB, McCarthy EE, Liu CC, Yee JL et al (2023) Dynamic CD8(+) T\u00a0cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes. Cell 186(6):1127-1143.e1118","journal-title":"Cell"},{"key":"4187_CR25","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/bs.apcsb.2024.02.002","volume":"140","author":"R Tiwari","year":"2024","unstructured":"Tiwari R, Singh VK, Kumar A, Gautam V, Kumar R (2024) MHC tetramer technology: exploring T cell biology in health and disease. Adv Protein Chem Struct Biol 140:327\u2013345","journal-title":"Adv Protein Chem Struct Biol"},{"issue":"5","key":"4187_CR26","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/cdd.2017.30","volume":"24","author":"EM Carrington","year":"2017","unstructured":"Carrington EM, Zhan Y, Brady JL, Zhang JG, Sutherland RM, Anstee NS et al (2017) Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo. Cell Death Differ 24(5):878\u2013888","journal-title":"Cell Death Differ"},{"issue":"1","key":"4187_CR27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/path.5924","volume":"258","author":"T Skroblyn","year":"2022","unstructured":"Skroblyn T, Joedicke JJ, Pfau M, Kr\u00fcger K, Bourquin JP, Izraeli S et al (2022) CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment. J Pathol 258(1):12\u201325","journal-title":"J Pathol"},{"issue":"23","key":"4187_CR28","doi-asserted-by":"crossref","first-page":"12737","DOI":"10.3390\/ijms222312737","volume":"22","author":"HC Tsai","year":"2021","unstructured":"Tsai HC, Lai YY, Hsu HC, Fong YC, Lien MY, Tang CH (2021) CCL4 stimulates cell migration in human osteosarcoma via the mir-3927\u20133p\/Integrin \u03b1v\u03b23 Axis. Int J Mol Sci 22(23):12737","journal-title":"Int J Mol Sci"},{"issue":"2","key":"4187_CR29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.it.2011.11.001","volume":"33","author":"L Martinez-Pomares","year":"2012","unstructured":"Martinez-Pomares L, Gordon S (2012) CD169+ macrophages at the crossroads of antigen presentation. Trends Immunol 33(2):66\u201370","journal-title":"Trends Immunol"},{"issue":"4","key":"4187_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ni.1853","volume":"11","author":"P Barral","year":"2010","unstructured":"Barral P, Polzella P, Bruckbauer A, van Rooijen N, Besra GS, Cerundolo V, Batista FD (2010) CD169(+) macrophages present lipid antigens to mediate early activation of iNKT cells in lymph nodes. Nat Immunol 11(4):303\u2013312","journal-title":"Nat Immunol"},{"issue":"5","key":"4187_CR31","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.cell.2019.10.028","volume":"179","author":"DP Hollern","year":"2019","unstructured":"Hollern DP, Xu N, Thennavan A, Glodowski C, Garcia-Recio S, Mott KR et al (2019) B cells and T follicular helper cells mediate response to checkpoint inhibitors in high mutation burden mouse models of breast cancer. Cell 179(5):1191-1206.e1121","journal-title":"Cell"},{"key":"4187_CR32","doi-asserted-by":"crossref","first-page":"111625","DOI":"10.1016\/j.intimp.2024.111625","volume":"129","author":"S Zheng","year":"2024","unstructured":"Zheng S, Yang B, Li L, Chen M, Zhang L, Chi W et al (2024) CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+\u00a0T cell infiltration. Int Immunopharmacol 129:111625","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"4187_CR33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1182\/blood-2005-02-0817","volume":"106","author":"KS Boles","year":"2005","unstructured":"Boles KS, Barchet W, Diacovo T, Cella M, Colonna M (2005) The tumor suppressor TSLC1\/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM. Blood 106(3):779\u2013786","journal-title":"Blood"},{"issue":"2","key":"4187_CR34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41577-019-0223-7","volume":"20","author":"A Kallies","year":"2020","unstructured":"Kallies A, Zehn D, Utzschneider DT (2020) Precursor exhausted T cells: key to successful immunotherapy? Nat Rev Immunol 20(2):128\u2013136","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"4187_CR35","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.21037\/tlcr-24-284","volume":"13","author":"L Ye","year":"2024","unstructured":"Ye L, Ryu H, Granadier D, Nguyen LT, Simoni Y, Dick I et al (2024) Stem-like exhausted CD8 T cells in pleural effusions predict improved survival in non-small cell lung cancer (NSCLC) and mesothelioma. Transl Lung Cancer Res 13(9):2352\u20132372","journal-title":"Transl Lung Cancer Res"},{"issue":"9","key":"4187_CR36","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ccell.2024.08.007","volume":"42","author":"K Wang","year":"2024","unstructured":"Wang K, Coutifaris P, Brocks D, Wang G, Azar T, Solis S et al (2024) Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8(+) T\u00a0cells. Cancer Cell 42(9):1582-1597.e1510","journal-title":"Cancer Cell"},{"key":"4187_CR37","doi-asserted-by":"crossref","first-page":"674558","DOI":"10.3389\/fmolb.2021.674558","volume":"8","author":"EF Goode","year":"2021","unstructured":"Goode EF, Roussos Torres ET, Irshad S (2021) Lymph node immune profiles as predictive biomarkers for immune checkpoint inhibitor response. Front Mol Biosci 8:674558","journal-title":"Front Mol Biosci"},{"issue":"563","key":"4187_CR38","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1126\/scitranslmed.aay3575","volume":"12","author":"DM Francis","year":"2020","unstructured":"Francis DM, Manspeaker MP, Schudel A, Sestito LF, O\u2019Melia MJ, Kissick HT et al (2020) Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy. Sci Transl Med 12(563):3575","journal-title":"Sci Transl Med"},{"issue":"1","key":"4187_CR39","doi-asserted-by":"crossref","first-page":"1684714","DOI":"10.1080\/2162402X.2019.1684714","volume":"9","author":"S Ma","year":"2020","unstructured":"Ma S, Chee J, Fear VS, Forbes CA, Boon L, Dick IM et al (2020) Pre-treatment tumor neo-antigen responses in draining lymph nodes are infrequent but predict checkpoint blockade therapy outcome. Oncoimmunology 9(1):1684714","journal-title":"Oncoimmunology"},{"issue":"17","key":"4187_CR40","doi-asserted-by":"crossref","first-page":"9401","DOI":"10.3390\/ijms22179401","volume":"22","author":"MF Fransen","year":"2021","unstructured":"Fransen MF, van Hall T, Ossendorp F (2021) Immune checkpoint therapy: tumor draining lymph nodes in the spotlights. Int J Mol Sci 22(17):9401","journal-title":"Int J Mol Sci"},{"key":"4187_CR41","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124507","author":"MF Fransen","year":"2018","unstructured":"Fransen MF, Schoonderwoerd M, Knopf P, Camps MG, Hawinkels LJ, Kneilling M et al (2018) Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.124507","journal-title":"JCI Insight"},{"issue":"5","key":"4187_CR42","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","volume":"38","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer F, van Gulijk M, Mulder EE, Lukkes M, Klaase L, van den Bosch T et al (2020) The PD-1\/PD-L1-checkpoint restrains T\u00a0cell immunity in tumor-draining lymph nodes. Cancer Cell 38(5):685-700.e688","journal-title":"Cancer Cell"},{"issue":"1","key":"4187_CR43","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41392-024-01838-9","volume":"9","author":"F He","year":"2024","unstructured":"He F, Wu Z, Liu C, Zhu Y, Zhou Y, Tian E et al (2024) Targeting BCL9\/BCL9L enhances antigen presentation by promoting conventional type 1 dendritic cell (cDC1) activation and tumor infiltration. Signal Transduct Target Ther 9(1):139","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"4187_CR44","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.immuni.2021.08.026","volume":"54","author":"JM Schenkel","year":"2021","unstructured":"Schenkel JM, Herbst RH, Canner D, Li A, Hillman M, Shanahan SL et al (2021) Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1(+) CD8(+) T\u00a0cells in tumor-draining lymph nodes. Immunity 54(10):2338-2353.e2336","journal-title":"Immunity"},{"issue":"4","key":"4187_CR45","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1158\/2326-6066.CIR-24-0421","volume":"13","author":"E Gobbini","year":"2025","unstructured":"Gobbini E, Hubert M, Doffin AC, Eberhardt A, Hermet L, Li D et al (2025) The spatial organization of cDC1 with CD8+ T cells is critical for the response to immune checkpoint inhibitors in patients with Melanoma. Cancer Immunol Res 13(4):517\u2013526","journal-title":"Cancer Immunol Res"},{"issue":"4","key":"4187_CR46","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.immuni.2022.03.006","volume":"55","author":"S D\u00e4hling","year":"2022","unstructured":"D\u00e4hling S, Mansilla AM, Kn\u00f6pper K, Grafen A, Utzschneider DT, Ugur M et al (2022) Type 1 conventional dendritic cells maintain and guide the differentiation of precursors of exhausted T\u00a0cells in distinct cellular niches. Immunity 55(4):656-670.e658","journal-title":"Immunity"},{"issue":"5","key":"4187_CR47","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ccell.2025.02.017","volume":"43","author":"S Lamorte","year":"2025","unstructured":"Lamorte S, Quevedo R, Jin R, Neufeld L, Liu ZQ, Ciudad MT et al (2025) Lymph node macrophages drive immune tolerance and resistance to cancer therapy by induction of the immune-regulatory cytokine IL-33. Cancer Cell 43(5):955\u2013969","journal-title":"Cancer Cell"},{"issue":"3","key":"4187_CR48","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ymthe.2024.01.020","volume":"32","author":"K Kubara","year":"2024","unstructured":"Kubara K, Yamazaki K, Miyazaki T, Kondo K, Kurotaki D, Tamura T, Suzuki Y (2024) Lymph node macrophages drive innate immune responses to enhance the anti-tumor efficacy of mRNA vaccines. Mol Ther 32(3):704\u2013721","journal-title":"Mol Ther"},{"issue":"2","key":"4187_CR49","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00281-023-00988-2","volume":"45","author":"P Sadhukhan","year":"2023","unstructured":"Sadhukhan P, Seiwert TY (2023) The role of macrophages in the tumor microenvironment and tumor metabolism. Semin Immunopathol. 45(2):187\u2013201","journal-title":"Semin Immunopathol"},{"key":"4187_CR50","doi-asserted-by":"crossref","first-page":"114504","DOI":"10.1016\/j.biopha.2023.114504","volume":"161","author":"L Li","year":"2023","unstructured":"Li L, Tian Y (2023) The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment. Biomed Pharmacother 161:114504","journal-title":"Biomed Pharmacother"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04187-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04187-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04187-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T17:20:20Z","timestamp":1763054420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04187-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4187"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04187-w","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"14 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board at each participating hospital (Cancer Hospital, Chinese Academy of Medical Sciences: 23\/139\u20133881, Shanxi Cancer Hospital: YW2023057).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"326"}}